Shiramizu T, Nakamura K, Hida M, Shinbo T, Nakayama M, Saitoh H, Satoh T, Hata J, Tsuji K
Tokai J Exp Clin Med. 1981 Jul;6(3):315-9.
Azathioprine was withdrawn from five recipients after renal transplantation because of hepatic damage. In three out of five cases, clinical courses were uneventful for more than 1 year after withdrawal (Group A). In the other two cases, rejection episodes occurred 3 and 5 months after withdrawal (Group B). Differences in histocompatibility, the interval between the operation and withdrawal, and the maintenance dosis of prednisolone were not practically striking in either group, but rejection episodes occurred early in group B. We evaluated the results and considered the mechanisms of tolerance after withdrawal of azathioprine because of hepatic damage in renal allograft recipients.
五名肾移植受者因肝损伤在肾移植后停用硫唑嘌呤。五例中有三例在停药后1年多临床过程平稳(A组)。另外两例在停药后3个月和5个月发生排斥反应(B组)。两组在组织相容性、手术与停药间隔以及泼尼松龙维持剂量方面的差异实际上并不显著,但B组排斥反应发生较早。我们评估了结果并探讨了肾移植受者因肝损伤停用硫唑嘌呤后耐受的机制。